ZBH
Income statement / Annual
Last year (2023), Zimmer Biomet Holdings, Inc.'s total revenue was $7.39 B,
an increase of 6.55% from the previous year.
In 2023, Zimmer Biomet Holdings, Inc.'s net income was $1.02 B.
See Zimmer Biomet Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$7.39 B
|
$6.94 B
|
$6.83 B
|
$7.02 B
|
$7.98 B
|
$7.93 B
|
$7.82 B
|
$7.68 B
|
$6.00 B
|
$4.67 B
|
| Cost of Revenue |
$2.08 B |
$2.02 B |
$1.96 B |
$2.13 B |
$2.25 B |
$2.27 B |
$2.13 B |
$2.37 B |
$1.86 B |
$1.25 B |
| Gross Profit |
$5.31 B |
$4.92 B |
$4.87 B |
$4.90 B |
$5.73 B |
$5.66 B |
$5.69 B |
$5.31 B |
$4.14 B |
$3.42 B |
| Gross Profit Ratio |
0.72 |
0.71 |
0.71 |
0.7 |
0.72 |
0.71 |
0.73 |
0.69 |
0.69 |
0.73 |
| Research and Development
Expenses |
$458.70 M
|
$406.00 M
|
$435.80 M
|
$372.00 M
|
$449.30 M
|
$391.70 M
|
$367.40 M
|
$365.60 M
|
$268.80 M
|
$188.30 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$3.18 B
|
$0.00
|
$3.38 B
|
$2.97 B
|
$2.93 B
|
$2.28 B
|
$1.82 B
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$2.82 B
|
$2.76 B
|
$2.84 B
|
$3.18 B
|
$3.34 B
|
$3.38 B
|
$2.97 B
|
$2.93 B
|
$2.28 B
|
$1.82 B
|
| Other Expenses |
$0.00 |
$560.60 M |
$582.30 M |
$648.50 M |
$666.70 M |
-$15.60 M |
-$18.30 M |
-$71.30 M |
-$36.90 M |
-$39.60 M |
| Operating Expenses |
$3.28 B |
$3.73 B |
$3.86 B |
$4.20 B |
$4.46 B |
$4.51 B |
$3.95 B |
$3.86 B |
$2.90 B |
$2.01 B |
| Cost And Expenses |
$6.12 B |
$5.75 B |
$5.82 B |
$6.33 B |
$6.71 B |
$6.79 B |
$6.08 B |
$6.24 B |
$4.76 B |
$3.26 B |
| Interest Income |
$0.00 |
$164.80 M |
$208.40 M |
$212.10 M |
$226.90 M |
$3.30 M |
$2.20 M |
$2.90 M |
$9.40 M |
$11.90 M |
| Interest Expense |
$201.20 M |
$164.80 M |
$208.40 M |
$212.00 M |
$226.90 M |
$292.60 M |
$327.50 M |
$357.90 M |
$286.60 M |
$63.10 M |
| Depreciation &
Amortization |
$951.70 M
|
$926.40 M
|
$937.70 M
|
$1.03 B
|
$1.01 B
|
$1.04 B
|
$1.06 B
|
$1.03 B
|
$723.50 M
|
$375.80 M
|
| EBITDA |
$2.45 B
|
$2.21 B
|
$2.16 B
|
$969.70 M
|
$2.40 B
|
$1.06 B
|
$1.85 B
|
$1.79 B
|
$2.34 B
|
$1.78 B
|
| EBITDA Ratio |
0.33 |
0.29 |
0.29 |
0.25 |
0.28 |
0.27 |
0.36 |
0.31 |
0.32 |
0.3 |
| Operating Income Ratio
|
0.17
|
0.15
|
0.13
|
0.1
|
0.14
|
0
|
0.11
|
0.11
|
0.05
|
0.22
|
| Total Other
Income/Expenses Net |
-$210.40 M
|
-$292.80 M
|
-$361.30 M
|
-$357.50 M
|
-$231.70 M
|
-$304.90 M
|
-$334.70 M
|
-$421.50 M
|
-$314.10 M
|
-$97.90 M
|
| Income Before Tax |
$1.07 B |
$403.50 M |
$499.00 M |
-$274.40 M |
$905.80 M |
-$271.10 M |
$479.60 M |
$401.60 M |
$12.30 M |
$943.90 M |
| Income Before Tax Ratio
|
0.14
|
0.06
|
0.07
|
-0.04
|
0.11
|
-0.03
|
0.06
|
0.05
|
0
|
0.2
|
| Income Tax Expense |
$42.20 M |
$112.30 M |
$53.50 M |
-$137.00 M |
-$225.70 M |
$108.20 M |
-$1.36 B |
$100.00 M |
-$36.60 M |
$224.90 M |
| Net Income |
$1.02 B |
$231.40 M |
$401.60 M |
-$137.40 M |
$1.13 B |
-$379.20 M |
$1.84 B |
$302.90 M |
$49.70 M |
$720.10 M |
| Net Income Ratio |
0.14 |
0.03 |
0.06 |
-0.02 |
0.14 |
-0.05 |
0.24 |
0.04 |
0.01 |
0.15 |
| EPS |
4.91 |
1.39 |
1.93 |
-0.66 |
5.52 |
-1.86 |
9.11 |
1.51 |
0.27 |
4.26 |
| EPS Diluted |
4.88 |
1.38 |
1.91 |
-0.66 |
5.47 |
-1.86 |
9.03 |
1.5 |
0.26 |
4.19 |
| Weighted Average Shares
Out |
$208.70 M
|
$209.60 M
|
$208.60 M
|
$207.00 M
|
$205.10 M
|
$203.50 M
|
$201.90 M
|
$200.00 M
|
$187.40 M
|
$169.00 M
|
| Weighted Average Shares
Out Diluted |
$209.70 M
|
$210.30 M
|
$210.40 M
|
$207.00 M
|
$206.70 M
|
$203.50 M
|
$203.70 M
|
$202.40 M
|
$189.80 M
|
$171.70 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
